These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 11241268

  • 1. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindán J.
    Cancer; 2001 Feb 25; 93(1):68-72. PubMed ID: 11241268
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H.
    Diagn Cytopathol; 2005 Mar 25; 32(3):151-5. PubMed ID: 15690338
    [Abstract] [Full Text] [Related]

  • 3. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY, Li GD, Liu WP, Xie B, Jiang YH.
    Diagn Cytopathol; 2011 Dec 25; 39(12):900-8. PubMed ID: 20836004
    [Abstract] [Full Text] [Related]

  • 4. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion.
    Ueda J, Iwata T, Ono M, Takahashi M.
    Diagn Cytopathol; 2006 Jan 25; 34(1):6-10. PubMed ID: 16355377
    [Abstract] [Full Text] [Related]

  • 5. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH, Kim GE, Choi YD, Lee JS, Lee JH, Nam JH, Choi C.
    Diagn Cytopathol; 2009 Apr 25; 37(4):258-61. PubMed ID: 19217030
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT, Gentile P, Tarectecan A, Fuchs A.
    Arch Pathol Lab Med; 1996 Oct 25; 120(10):959-66. PubMed ID: 12046609
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations.
    Frisman DM, McCarthy WF, Schleiff P, Buckner SB, Nocito JD, O'Leary TJ.
    Mod Pathol; 1993 Mar 25; 6(2):179-84. PubMed ID: 8483888
    [Abstract] [Full Text] [Related]

  • 12. Utility of HBME-1 immunostaining in serous effusions.
    Ascoli V, Carnovale-Scalzo C, Taccogna S, Nardi F.
    Cytopathology; 1997 Oct 25; 8(5):328-35. PubMed ID: 9313985
    [Abstract] [Full Text] [Related]

  • 13. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.
    Bailey ME, Brown RW, Mody DR, Cagle P, Ramzy I.
    Acta Cytol; 1996 Oct 25; 40(6):1212-6. PubMed ID: 8960030
    [Abstract] [Full Text] [Related]

  • 14. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions].
    Li XJ, Pan QJ, Shen GH, Liu XY, Sun YT.
    Zhonghua Zhong Liu Za Zhi; 2005 Jul 25; 27(7):438-41. PubMed ID: 16188134
    [Abstract] [Full Text] [Related]

  • 15. Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining.
    Kitazume H, Kitamura K, Mukai K, Inayama Y, Kawano N, Nakamura N, Sano J, Mitsui K, Yoshida S, Nakatani Y.
    Cancer; 2000 Feb 25; 90(1):55-60. PubMed ID: 10692217
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.